cyclandelate has been researched along with Diabetic Neuropathies in 4 studies
Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclandelate has the ability to improve the rheological properties of the blood and therefore may improve blood supply of peripheral nerves." | 2.67 | Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study. ( Bertelsmann, FW; Drukarch, B; Heimans, JJ; Ijff, GA; Matthaei, I; Nauta, J; Strijers, RL, 1991) |
| "Previous trials have demonstrated a clinical and electrophysiological improvement of diabetic peripheral polyneuropathy in diabetic patients treated with cyclandelate at a dosage of 1600 mg/day." | 2.66 | Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy. ( De Leeuw, IH; Driessens, M; Moeremans, M; Van Rooy, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canal, N | 1 |
| Comi, G | 1 |
| Marchettini, P | 1 |
| Pozza, G | 1 |
| van der Drift, JH | 1 |
| Heimans, JJ | 1 |
| Drukarch, B | 1 |
| Matthaei, I | 1 |
| Ijff, GA | 1 |
| Bertelsmann, FW | 1 |
| Strijers, RL | 1 |
| Nauta, J | 1 |
| De Leeuw, IH | 1 |
| Van Rooy, P | 1 |
| Moeremans, M | 1 |
| Driessens, M | 1 |
3 trials available for cyclandelate and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of cyclandelate on diabetic peripheral neuropathy.
Topics: Aged; Clinical Trials as Topic; Cyclandelate; Diabetic Neuropathies; Double-Blind Method; Female; Hu | 1984 |
Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study.
Topics: Adult; Aged; Cyclandelate; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; Hu | 1991 |
Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
Topics: Adult; Aged; Auditory Threshold; Clinical Trials as Topic; Cyclandelate; Diabetes Mellitus, Type 1; | 1987 |
1 other study available for cyclandelate and Diabetic Neuropathies
| Article | Year |
|---|---|
Cyclandelate in diabetic radiculoneuropathy.
Topics: Cyclandelate; Diabetic Neuropathies; Follow-Up Studies; Humans; Mandelic Acids; Spinal Nerve Roots | 1980 |